Madrigal Pharmaceuticals, Inc.
MDGL
$301.66
-$6.12-1.99%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -7.25% | -5.59% | -0.12% | 67.01% | 172.92% |
| Total Receivables | 76.68% | 341.56% | -- | -- | -- |
| Inventory | 290.91% | 23.23% | 728.10% | -- | -- |
| Prepaid Expenses | -33.91% | 39.42% | 6.61% | 345.56% | 1.03% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | 0.00% | -- | -- | -- |
| Total Current Assets | -2.89% | -2.57% | 1.66% | 68.52% | 170.64% |
|
|
|||||
| Total Current Assets | -2.89% | -2.57% | 1.66% | 68.52% | 170.64% |
| Net Property, Plant & Equipment | -3.95% | 51.70% | -5.32% | 1.90% | 30.90% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -1.87% | -1.85% | -1.80% | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -2.89% | -2.41% | 1.62% | 68.96% | 169.18% |
|
|
|||||
| Total Accounts Payable | -5.15% | 411.07% | -58.22% | -23.23% | 69.51% |
| Total Accrued Expenses | -4.82% | 13.31% | 25.30% | 2.55% | 8.92% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 11.96% | 57.63% | 2.77% | 2.85% | 2.73% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -4.82% | 42.09% | 9.46% | -3.55% | 18.95% |
|
|
|||||
| Total Current Liabilities | -4.82% | 42.09% | 9.46% | -3.55% | 18.95% |
| Long-Term Debt | 0.41% | 0.41% | 0.41% | 0.57% | 0.66% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -13.44% | 30.67% | -13.88% | -11.89% | -10.36% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -2.78% | 22.02% | 4.82% | -1.57% | 9.04% |
|
|
|||||
| Common Stock & APIC | 1.49% | 1.02% | 6.79% | 34.09% | 39.70% |
| Retained Earnings | -3.41% | -6.54% | -10.24% | -11.04% | -9.17% |
| Treasury Stock & Other | -63.18% | 445.38% | -113.95% | -136.75% | 1,214.29% |
| Total Common Equity | -2.93% | -9.33% | 0.75% | 109.89% | 1,721.80% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -2.93% | -9.33% | 0.75% | 109.89% | 1,721.80% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.93% | -9.33% | 0.75% | 109.89% | 1,721.80% |
|
|
|||||